1. Angell, M. 2004. The Truth about the Drug Companies: How They Deceive Us and What to Do about It. New York: Random House.
2. Applbaum, K. 2009. Getting to Yes: Corporate Power and the Creation of a Psychopharmaceutical Blockbuster. Culture, Medicine and Psychiatry 33: 185–215.
3. ———. 2010. Shadow Science: Zyprexa, Eli Lilly, and the Globalization of Pharmaceutical Damage Control. BioSocieties 5: 236–255.
4. Avorn, J. 2004. Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs. New York: Knopf.
5. Boussageon, R., T. Bejan-Angoulvant, M. Saadatian-Elahi, et al. 2011. Effect Of Intensive Glucose Lowering Treatment On All Cause Mortality, Cardiovascular Death, And Microvascular Events In Type 2 Diabetes: Meta-Analysis Of Randomised Controlled Trials. British Medical Journal 343: d4169.